Sermorelin vs CJC-1295

Q: Which is better with ipamorelin?

Either can be paired with a GHRP such as ipamorelin , since a GHRH analogue and a GHRP pull different levers. The short-acting pair (sermorelin or Mod GRF plus ipamorelin) aims at a cleaner pulse; the long-acting CJC-1295 DAC aims at steady elevation. None of it is a tested, approved protocol.

Two GHRH analogues that do the same job — tell the pituitary to release growth hormone — but on completely different timescales: minutes against a week.

Neither is an approved medicine for this use. Sermorelin was once approved and later withdrawn for commercial reasons; CJC-1295 was never approved. Both are sold as research chemicals and both are banned in sport. This is a factual comparison, not advice.

	SermorelinGeref	CJC-1295 with DAC
What it is	Native GHRH(1-29) fragment	GHRH analogue + albumin-binding DAC
Half-life	~11–12 minutes	~6–8 days
Dosing	1x daily for the registered application; user protocols in adults cite 1x daily before sleep, sometimes 2x daily	1-2x per week; because of the half-life of 6-8 days, accumulation occurs over the first weeks
GH pattern	Brief, near-physiological pulse	Days-long elevation
Status	Was approved (Geref); now research chemical	Never approved; research chemical

Sermorelin

The native GHRH(1-29) fragment — the shortest active piece of the real hormone. It clears in minutes, producing a brief pulse of GH release that is close to the body’s own pattern. It was once an FDA-approved product (Geref), withdrawn in 2008 for commercial rather than safety reasons.

CJC-1295 with DAC

A modified GHRH analogue carrying a drug-affinity complex (DAC) that binds it to albumin, stretching its action to roughly 6–8 days. That turns the brief GHRH pulse into a sustained, days-long elevation — a bigger total signal, but further from the body’s natural rhythm. The short-acting version without DAC is essentially Mod GRF 1-29.

Sermorelin & CJC-1295: common questions

What is the difference between sermorelin and CJC-1295?

Both are GHRH analogues — they tell the pituitary to release growth hormone — but they last very differently. Sermorelin is the natural GHRH(1-29) fragment and is gone in minutes, giving a brief pulse. CJC-1295 with DAC is engineered to bind albumin and keep working for roughly a week.

Is CJC-1295 stronger than sermorelin?

It produces a much longer-lasting rise in GH-releasing signal, so total exposure is higher — but “stronger” is not automatically better. A short pulse like sermorelin’s is closer to the body’s own rhythm; a days-long elevation is further from it. Neither is an approved regimen for this use.

Which is better with ipamorelin?

Either can be paired with a GHRP such as ipamorelin, since a GHRH analogue and a GHRP pull different levers. The short-acting pair (sermorelin or Mod GRF plus ipamorelin) aims at a cleaner pulse; the long-acting CJC-1295 DAC aims at steady elevation. None of it is a tested, approved protocol.

Are sermorelin and CJC-1295 legal or banned in sport?

Sermorelin was once FDA-approved (as Geref) but was withdrawn for commercial reasons and is now sold as a research chemical; CJC-1295 was never approved. Both are GH-releasing factors on the WADA Prohibited List (S2) and banned at all times. See doping status.

Sermorelin · CJC-1295 with DAC · Growth hormone hub · MK-677 vs ipamorelin